Clinical Trial Assessing the Safety of Neoadjuvant Palbociclib in Combination With Endocrine Therapy
Clinical trial NCT05069038 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05069038
- Sponsor
- University of Nebraska
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-02
- Primary completion
- 2026-09-01
- Enrollment
- 51
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.